High glucose-activated NF-κB via AGEs, ROS or PKC increased expression of genes contributing to endothelial dysfunction, such as ET-1, adhesion molecules and inflammatory cytokines [35], [40], [41]. The gene discussed is PRRT2; the disease is endothelial dysfunction.